Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
J Cosmet Dermatol ; 11(4): 272-8, 2012 Dec.
Article En | MEDLINE | ID: mdl-23174050

BACKGROUND: Propionibacterium acnes is a major contributing factor to the inflammatory component of acne. The interaction of P. acnes with keratinocytes leads to an innate immune response via activation of toll-like receptors (TLR2, TLR4) resulting in the production and secretion of pro-inflammatory mediators. SIG1273, an isoprenylcysteine small molecule modulates inflammatory signaling pathways and kills P. acnes. SIG1273 represents a novel cosmetic functional ingredient that provides relief from blemishes in acne prone skin. OBJECTIVE: To assess the keratinocyte response and microbial growth of SIG1273 in vitro and evaluate the tolerability of SIG1273 gel applied topically in acne prone subjects. METHODS: For in vitro studies, human keratinocytes were exposed in culture to live P. acnes and peptidoglycan (PGN) to induce IL-8 production. P. acnes were cultured to determine minimal inhibitory concentration and minimal bactericidal concentration values. A total of 30 subjects were randomized in a double-blind controlled trial receiving 3% SIG1273 gel or vehicle for 6 weeks. Evaluation included inflammatory lesions, noninflammatory lesions, microcomedones, Sebutape scores, and P. acnes counts. RESULTS: In vitro studies demonstrate SIG1273 inhibits P. acnes-induced IL-8 production and inhibits P. acnes growth. SIG1273 gel was well tolerated with no signs of stinging, redness, or itching. Furthermore, improvement in some aspects of acne was observed in subjects applying SIG1273 gel, including inflammatory lesions, microcomedone counts and Sebutape scores. Facial scrubs taken to measure P. acnes colony-forming units showed those applying SIG1273 gel had ~1.0 Log 10 colony reduction over the length of the study, a statistically significantly improvement when compared with vehicle. No significant effects above vehicle were observed for noninflammatory lesions. CONCLUSIONS: SIG1273 represents a novel cosmetic functional ingredient that provides a safe dual modulating benefit to individuals with acne prone skin by reducing P. acnes counts and reducing inflammation.


Acne Vulgaris/drug therapy , Anti-Infective Agents, Local/pharmacology , Anti-Infective Agents, Local/therapeutic use , Cysteine/analogs & derivatives , Keratinocytes/drug effects , Propionibacterium acnes/drug effects , Acne Vulgaris/metabolism , Acne Vulgaris/microbiology , Adolescent , Adult , Analysis of Variance , Colony Count, Microbial , Cosmetics/chemistry , Cosmetics/pharmacology , Cysteine/pharmacology , Cysteine/therapeutic use , Double-Blind Method , Facial Dermatoses/drug therapy , Facial Dermatoses/metabolism , Facial Dermatoses/microbiology , Female , Gels , Humans , Interleukin-8/biosynthesis , Keratinocytes/metabolism , Male , Microbial Sensitivity Tests , Peptidoglycan/pharmacology , Propionibacterium acnes/growth & development , Sebum/metabolism , Severity of Illness Index , Young Adult
2.
J Neurosci ; 31(19): 6963-71, 2011 May 11.
Article En | MEDLINE | ID: mdl-21562258

α-Synuclein (α-Syn) is a key protein that accumulates as hyperphosphorylated aggregates in pathologic hallmark features of Parkinson's disease (PD) and other neurodegenerative disorders. Phosphorylation of this protein at serine 129 is believed to promote its aggregation and neurotoxicity, suggesting that this post-translational modification could be a therapeutic target. Here, we demonstrate that phosphoprotein phosphatase 2A (PP2A) dephosphorylates α-Syn at serine 129 and that this activity is greatly enhanced by carboxyl methylation of the catalytic C subunit of PP2A. α-Syn-transgenic mice raised on a diet supplemented with eicosanoyl-5-hydroxytryptamide, an agent that enhances PP2A methylation, dramatically reduced both α-Syn phosphorylation at Serine 129 and α-Syn aggregation in the brain. These biochemical changes were associated with enhanced neuronal activity, increased dendritic arborizations, and reduced astroglial and microglial activation, as well as improved motor performance. These findings support the notion that serine 129 phosphorylation of α-Syn is of pathogenetic significance and that promoting PP2A activity is a viable disease-modifying therapeutic strategy for α-synucleinopathies such as PD.


Neurodegenerative Diseases/metabolism , Neurons/metabolism , Phosphoprotein Phosphatases/metabolism , Serotonin/analogs & derivatives , alpha-Synuclein/metabolism , Animals , Astrocytes/metabolism , Astrocytes/pathology , Blotting, Western , Brain/metabolism , Brain/pathology , Cell Line , Cells, Cultured , Dendrites/genetics , Dendrites/metabolism , Dendrites/pathology , Disease Models, Animal , Immunohistochemistry , Methylation , Mice , Mice, Transgenic , Microglia/metabolism , Microglia/pathology , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/pathology , Neurons/pathology , Phosphorylation/physiology , Serotonin/metabolism , alpha-Synuclein/genetics
3.
Dev Biol ; 348(1): 3-11, 2010 Dec 01.
Article En | MEDLINE | ID: mdl-20826130

The categorical data set is an important data class in experimental biology and contains data separable into several mutually exclusive categories. Unlike measurement of a continuous variable, categorical data cannot be analyzed with methods such as the Student's t-test. Thus, these data require a different method of analysis to aid in interpretation. In this article, we will review issues related to categorical data, such as how to plot them in a graph, how to integrate results from different experiments, how to calculate the error bar/region, and how to perform significance tests. In addition, we illustrate analysis of categorical data using experimental results from developmental biology and virology studies.


Biology/statistics & numerical data , Animals , Confidence Intervals , Data Display , Data Interpretation, Statistical , Developmental Biology/statistics & numerical data , Virology/statistics & numerical data
4.
J Virol ; 80(17): 8371-8, 2006 Sep.
Article En | MEDLINE | ID: mdl-16912288

We have characterized the function of the human cytomegalovirus US24 gene, a US22 gene family member. Two US24-deficient mutants (BADinUS24 and BADsubUS24) exhibited a 20- to 30-fold growth defect, compared to their wild-type parent (BADwt), after infection at a relatively low (0.01 PFU/cell) or high (1 PFU/cell) input multiplicity. Representative virus-encoded proteins and viral DNA accumulated with normal kinetics to wild-type levels after infection with mutant virus when cells received equal numbers of mutant and wild-type infectious units. Further, the proteins were properly localized and no ultrastructural differences were found by electron microscopy in mutant-virus-infected cells compared to wild-type-virus-infected cells. However, virions produced by US24-deficient mutants had a 10-fold-higher genome-to-PFU ratio than wild-type virus. When infections were performed using equal numbers of input virus particles, the expression of immediate-early, early, and late viral proteins was substantially delayed and decreased in the absence of US24 protein. This delay is not due to inefficient virus entry, since two tegument proteins and viral DNA moved to the nucleus equally well in mutant- and wild-type-virus-infected cells. In summary, US24 is a virion protein and virions produced by US24-deficient viruses exhibit a block to the human cytomegalovirus replication cycle after viral DNA reaches the nucleus and before immediate-early mRNAs are transcribed.


Cytomegalovirus/physiology , Viral Proteins/metabolism , Virion/metabolism , Virus Replication , Cells, Cultured , Cytomegalovirus/genetics , Cytomegalovirus/metabolism , Cytomegalovirus/pathogenicity , Fibroblasts/virology , Humans , Viral Proteins/genetics , Virion/genetics , Virion/pathogenicity , Virion/physiology
...